Situation normale

AMBIXX
 SRL

2960 Brecht
Since 07/04/2016
BE0651692322
Financial Health Indicator
6
Equity
€375.2K
+75% YoY
Gross Operating Margin
€261.4K
-40% YoY
EBITDA
€259.9K
-40% YoY
Gain/Loss
€160.8K
-57% YoY

AMBIXX’s business network visualized

Explore our interactive spiderweb to visually navigate AMBIXX’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb AMBIXX
AMBIXX
  • Laurent COOREMAN
    2960 Brecht
    Since 2016
  • Marleen SLAETS
    2960 Brecht
    Since 2016

Detailed insights into AMBIXX’s financial history

See financial trends including, equity, operating income, profit/loss and employees of AMBIXX. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023 2022 2021 2020 2019
Equity
375.2K
214.4K
-162.8K
-88.2K
-35.8K
Gross Operating Margin
261.4K
436.1K
-39.7K
-49.1K
-54.5K
Gain/Loss
160.8K
377.2K
-74.6K
-52.3K
-57.4K

Find similar companies like AMBIXX

Find more companies with similar activities to AMBIXX from our extensive database.

Frequently asked questions about AMBIXX

  • Where is AMBIXX located?

    AMBIXX’s headquarters is located in Kapelstraat 15 , 2960 Brecht.

  • Who are the directors of AMBIXX?

    AMBIXX’s directors include
    • Laurent COOREMAN
    • Marleen SLAETS

  • When was AMBIXX founded?

    AMBIXX was founded in 2016-04-07. AMBIXX has been active for 9 years.

  • What are AMBIXX’s NACEBEL codes?

    AMBIXX’s NACEBEL codes are
    • 46460 Commerce de gros de produits pharmaceutiques (2008)
    • 73120 Régie publicitaire de médias (2008)

  • What is AMBIXX’s VAT number?

    AMBIXX’s VAT number is BE0651692322.

  • What is AMBIXX’s juridical form?

    AMBIXX’s juridical type is Société à responsabilité limitée (SRL).

  • How is the financial situation of AMBIXX?

    openthebox has estimated that AMBIXX’s financial health score to be 6/10.